A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.
Identificadores
Identificadores
Data de publicación
2014Título da revista
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Tipo de contido
Artigo